PATENT CLAIM ANALYSIS

Application Number: 16107605
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "293000"]

Abstract:
Disclosed are alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, as Toll-like receptor-7 and -8 agonists for enhancing immune responses. Also provided are methods of making pharmaceutical compositions containing these compounds. The present disclosure also describes methods of use for the alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, and pharmaceutical compositions containing these compounds for the treatment of disease in a subject.

Claim (Index 13):
The compound of  claim 5 , or a salt thereof, wherein m is 1 or 2.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 96.0
- Lexical Diversity: 1.67442
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15848349', '13475284', '14279416', '15793820', '13832179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8089482453482234
- 35 USC 102 Novelty (BERT): 0.5255878708680785
- Combined Prediction Score: 0.7806122079002089
- Mean Citation Score: 308.7829920000001
- Max Citation Score: 313.4957
- Similarity Product: 181.4587738797903

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test